Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Clinical trial NCT05892393 · RECRUITING

Trial details

NCT number: NCT05892393
Sponsor: Robert Flavell, MD, PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Plasma Cell Myeloma

Start date: 2023-06-16
Primary completion: 2026-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.